Top Section/Ad
Top Section/Ad
Most recent
One senior investment banker I know is taking networking and relationship building to a whole new level
As the end of the year looms and everyone rushes to clear their annual leave, great examples arise of what to learn from your boss
Despite the often dry nature of the loan business in Asia, there can be some hidden perks from deals
I've recently learnt the four Rs of life: reduce, reuse, recycle and regift
More articles/Ad
More articles/Ad
More articles
-
I was pleased to see Australia’s residential mortgage-backed securities market going at full pace this week. Bank of Queensland priced Australia’s largest RMBS of the year, after bringing a heavily increased A$1.6bn ($1.44bn) issue — and that seems to have prompted a rush to market from other issuers.
-
Equity markets are succumbing to a summer slump, and a big slowdown in new deals has left many bankers waiting impatiently for the next big Chinese IPO to liven things up. But it’s not summer everywhere. Australians are coming to the end of their winter, and a spate of equity placements have kept ECM bankers busy. But I have to wonder, where are the IPOs?
-
It is always a fair bet at the start of the year that the markets will slow down in the middle of August, giving me some time to take a holiday and keep a closer eye on TaiTai’s spending sprees.
-
Chinese property companies are coming back to the international bond markets after months of silence, hoping to raise money from the same investors who got severely burnt earlier this year when bond prices in the sector plummeted. But this time investors have more reason to be confident — and to push for juicy pricing.
-
I have to tip my hat to Temasek. The borrower made its sterling debut this week in a deal that every bank under the sun was clamouring to be mandated on, but that was clearly not enough of a challenge. It then decided to issue the longest maturity deal in its domestic market. Again.
-
The leveraged loan market is bracing itself for the biggest test of the year. The private equity firms circling Australia’s Healthscope are set to submit bids for the company this week.